Evidence map›Paper›PMID 40032350›Full record

ReviewZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Post-traumatic acquired hemophilia A: a case report and literature review].

Y Y Xie, M R Yang, M Z Zhang, Z L Deng, L H Wang, J Y Li, J J Zhao, B L Hua, Z Y Yan

Abstract readCase ReportsReviewEnglish Abstract
In one paragraph

Review in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Y Y XieDepartment of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
M R YangDepartment of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
M Z ZhangDepartment of Burn, Affiliated Hospital of North China University of Science and Technology, Tangshan 063000, China.
Z L DengDepartment of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
L H WangDepartment of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
J Y LiIntensive Care Unit, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.
J J ZhaoDepartment of Laboratory Medicine, Affiliated Hospital of North China University of Science and Technology Tangshan 063000, China.
B L HuaDepartment of Hematology, BeiJing ShiJiTan Hospital, Beijing 100038, China.
Z Y YanDepartment of Hematology, North China University of Science and Technology Affiliated Hospital, Tangshan 063000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired Hemophilia A is an acquired bleeding disorder characterized by reduced FⅧ activity due to the presence of autoantibodies against anticoagulant factor Ⅷ in the circulation. Laboratory tests are typically characterized by prolonged isolated activated partial thromboplastin time (APTT). Clinically, it often manifests as severe bleeding, and 50% of AHA patients can identify the cause. This article reports on a patient with post-traumatic AHA who rapidly improved after antibody removal and bypass replacement therapy, followed by wound healing following surgical intervention. A review of relevant literature is also conducted to enhance clinicians' awareness of AHA, which presents with normal coagulation initially and gradually develops into prolonged APTT accompanied by bleeding manifestations, aiming for early diagnosis and timely treatment.

Indexed as

Hemophilia AHumans

Identifiers

PMID40032350
PMCPMC13523902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.